Thermo Fisher Scientific
Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries
20 December 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimising pharmacovigilance case processing and safety data management processes. The new platform enhances CorEvitas clinical research registries offered by Thermo Fisher’s PPD clinical research business. CorEvidence’s first...
Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities
7 September 2023 -- Massachusetts, US -- Thermo Fisher Scientific, the world leader in serving science, and the National Minority Quality Forum (NMQF), an independent not-for-profit research and education organisation, today announced a collaboration to help bring clinical research to historically underserved patient populations through NMQF’s Alliance for Representative Clinical Trials (ARC). The collaboration supports...
Distributed Control System Facilitates Expansion for New Drugs Produced by Contract Manufacturing Organisation
Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up.
Thermo Fisher Scientific Introduces Decentralized Clinical Trials Network
10/05/2022 WILMINGTON, N.C.--(BUSINESS WIRE)-- The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced the creation of the PPD DCT Network to support global investigators and research sites participating in decentralized clinical trials (DCTs) for pharmaceutical and biotech customers.
Thermo Fisher Scientific Showcases Latest Innovations to Improve Biopharmaceutical and Proteomics Workflows
MAASTRICHT, Netherlands - IMSC 2022 - (August 29, 2022) - Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges. The company will showcase these innovations during the International Mass Spectrometry Conference...
Automated Dried Spot Sampling and Analysis System Redefines Workflow
The Thermo Scientific Transcend DSX-1 integrated sample prep and ultra-high-performance liquid chromatography (UHPLC) system delivers high throughput, sensitive and compliant analysis
Thermo Fisher Scientific Launches CE-IVD Marked Next-Generation Sequencing Instrument for Use in Clinical Labs
CARLSBAD, Calif., (March 29, 2022) -- Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in as little as a single day. Designed for use in clinical laboratories, the fully validated system enables users to perform both diagnostic testing and clinical...
New Portfolio of Chromatography and Mass Spectrometry Consumables Assures Quality and Performance
Langerwehe, Germany - (February 21, 2022) - A new collection of caps, vials, inserts, kits, well plates and mats improves analytical performance and sample security for chromatography and mass spectrometry users in routine and research laboratories, across a diverse range of sectors such as pharma, biopharma, clinical, food, environmental and academia.
Thermo Scientific Nicolet RaptIR FTIR Microscope Quickly Collects and Analyzes High-Spatial Resolution Data with Agility and Acuity
HILLSBORO, Ore., Feb. 3, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Thermo Scientific Nicolet RaptIR FTIR Microscope. It enables users of varying experience levels to quickly locate areas of interest, collect high-spatial resolution visual and infrared data, and generate accurate results with minimal time and effort.
Thermo Fisher Scientific Completes Acquisition of PeproTech, a Leader in Recombinant Proteins
WALTHAM, Mass., Jan. 5, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and PeproTech, Inc., a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash purchase price of approximately $1.85 billion.
